7 results on '"Gupta, Abha"'
Search Results
2. Identification of amygdala-expressed genes associated with autism spectrum disorder
- Author
-
Herrero, Maria Jesus, Velmeshev, Dmitry, Hernandez-Pineda, David, Sethi, Saarthak, Sorrells, Shawn, Banerjee, Payal, Sullivan, Catherine, Gupta, Abha R., Kriegstein, Arnold R., and Corbin, Joshua G.
- Published
- 2020
- Full Text
- View/download PDF
3. Additional germline findings from a tumor profiling program
- Author
-
Stjepanovic, Neda, Stockley, Tracy L., Bedard, Philippe L., McCuaig, Jeanna M., Aronson, Melyssa, Holter, Spring, Semotiuk, Kara, Leighl, Natasha B., Jang, Raymond, Krzyzanowska, Monika K., Oza, Amit M., Gupta, Abha, Elser, Christine, Ahmed, Lailah, Wang, Lisa, Kamel-Reid, Suzanne, Siu, Lillian L., and Kim, Raymond H.
- Published
- 2018
- Full Text
- View/download PDF
4. Perceptions of and decision making about clinical trials in adolescent and young adults with Cancer: a qualitative analysis
- Author
-
Bell, Jennifer A.H., Forcina, Victoria, Mitchell, Laura, Tam, Seline, Wang, Kate, Gupta, Abha A., and Lewin, Jeremy
- Published
- 2018
- Full Text
- View/download PDF
5. Neurogenetic analysis of childhood disintegrative disorder.
- Author
-
Gupta, Abha R., Westphal, Alexander, Yang, Daniel Y. J., Sullivan, Catherine A. W., Eilbott, Jeffrey, Zaidi, Samir, Voos, Avery, Vander Wyk, Brent C., Ventola, Pam, Waqar, Zainulabedin, Fernandez, Thomas V., Ercan-Sencicek, A. Gulhan, Walker, Michael F., Choi, Murim, Schneider, Allison, Hedderly, Tammy, Baird, Gillian, Friedman, Hannah, Cordeaux, Cara, and Ristow, Alexandra
- Subjects
- *
CHILDHOOD disintegrative disorder , *NEUROGENETICS , *AUTISM spectrum disorders , *INTELLECTUAL disabilities , *EYE tracking , *FUNCTIONAL magnetic resonance imaging , *DIAGNOSIS - Abstract
Background: Childhood disintegrative disorder (CDD) is a rare form of autism spectrum disorder (ASD) of unknown etiology. It is characterized by late-onset regression leading to significant intellectual disability (ID) and severe autism. Although there are phenotypic differences between CDD and other forms of ASD, it is unclear if there are neurobiological differences. Methods: We pursued a multidisciplinary study of CDD (n = 17) and three comparison groups: low-functioning ASD (n = 12), high-functioning ASD (n = 50), and typically developing (n = 26) individuals. We performed whole-exome sequencing (WES), copy number variant (CNV), and gene expression analyses of CDD and, on subsets of each cohort, non-sedated functional magnetic resonance imaging (fMRI) while viewing socioemotional (faces) and non-socioemotional (houses) stimuli and eye tracking while viewing emotional faces. Results: We observed potential differences between CDD and other forms of ASD. WES and CNV analyses identified one or more rare de novo, homozygous, and/or hemizygous (mother-to-son transmission on chrX) variants for most probands that were not shared by unaffected sibling controls. There were no clearly deleterious variants or highly recurrent candidate genes. Candidate genes that were found to be most conserved at variant position and most intolerant of variation, such as TRRAP, ZNF236, and KIAA2018, play a role or may be involved in transcription. Using the human BrainSpan transcriptome dataset, CDD candidate genes were found to be more highly expressed in non-neocortical regions than neocortical regions. This expression profile was similar to that of an independent cohort of ASD probands with regression. The non-neocortical regions overlapped with those identified by fMRI as abnormally hyperactive in response to viewing faces, such as the thalamus, cerebellum, caudate, and hippocampus. Eye-tracking analysis showed that, among individuals with ASD, subjects with CDD focused on eyes the most when shown pictures of faces. Conclusions: Given that cohort sizes were limited by the rarity of CDD, and the challenges of conducting non-sedated fMRI and eye tracking in subjects with ASD and significant ID, this is an exploratory study designed to investigate the neurobiological features of CDD. In addition to reporting the first multimodal analysis of CDD, a combination of fMRI and eye-tracking analyses are being presented for the first time for low-functioning individuals with ASD. Our results suggest differences between CDD and other forms of ASD on the neurobiological as well as clinical level. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
6. Rare deleterious mutations of the gene EFR3A in autism spectrum disorders.
- Author
-
Gupta, Abha R., Pirruccello, Michelle, Feng Cheng, Hyo Jung Kang, Fernandez, Thomas V., Baskin, Jeremy M., Murim Choi, Li Liu, Ercan-Sencicek, Adife Gulhan, Murdoch, John D., Klei, Lambertus, Neale, Benjamin M., Franjic, Daniel, Daly, Mark J., Lifton, Richard P., De Camilli, Pietro, Hongyu Zhao, Šestan, Nenad, and State, Matthew W.
- Subjects
- *
AUTISM spectrum disorders , *GENETIC mutation , *PHOSPHOINOSITIDES , *NUCLEOTIDE sequencing , *SACCHAROMYCES cerevisiae , *GENETICS - Abstract
Background Whole-exome sequencing studies in autism spectrum disorder (ASD) have identified de novo mutations in novel candidate genes, including the synaptic gene Eighty-five Requiring 3A (EFR3A). EFR3A is a critical component of a protein complex required for the synthesis of the phosphoinositide PtdIns4P, which has a variety of functions at the neural synapse. We hypothesized that deleterious mutations in EFR3A would be significantly associated with ASD. Methods We conducted a large case/control association study by deep resequencing and analysis of whole-exome data for coding and splice site variants in EFR3A. We determined the potential impact of these variants on protein structure and function by a variety of conservation measures and analysis of the Saccharomyces cerevisiae Efr3 crystal structure. We also analyzed the expression pattern of EFR3A in human brain tissue. Results Rare nonsynonymous mutations in EFR3A were more common among cases (16 / 2,196 = 0.73%) than matched controls (12 / 3,389 = 0.35%) and were statistically more common at conserved nucleotides based on an experiment-wide significance threshold (P = 0.0077, permutation test). Crystal structure analysis revealed that mutations likely to be deleterious were also statistically more common in cases than controls (P = 0.017, Fisher exact test). Furthermore, EFR3A is expressed in cortical neurons, including pyramidal neurons, during human fetal brain development in a pattern consistent with ASD-related genes, and it is strongly co-expressed (P < 2.2 × 10-16, Wilcoxon test) with a module of genes significantly associated with ASD. Conclusions Rare deleterious mutations in EFR3A were found to be associated with ASD using an experiment-wide significance threshold. Synaptic phosphoinositide metabolism was strongly implicated in syndromic forms of ASD. These data for EFR3A strengthen the evidence for the involvement of this pathway in idiopathic autism. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
7. Radiation Retinopathy: Case report and review.
- Author
-
Gupta, Abha, Dhawahir-Scala, Felipe, Smith, Amy, Young, Lorna, and Charles, Steve
- Subjects
OPHTHALMOLOGY ,RETROLENTAL fibroplasia ,RETINAL diseases ,RADIOTHERAPY ,VISUAL acuity - Abstract
Background: Ocular damage from radiation treatment is a well established phenomenon. Many factors are now known to influence the incidence of radiation retinopathy, including total dosage and daily fraction size. Patients who are diabetic, hypertensive or received previous chemotherapy are more susceptible to radiation retinopathy. Case Presentation: A 55 year old male was referred from the oncology department with epiphora. His medical history included Type 2 Insulin treated Diabetes Mellitus and hypertension. One year prior to presentation he had undergone a total rhinectomy with a 4 week course of postoperative radiotherapy for an aggressive sqaumous cell carcinoma of the nose. On examination the visual acuity was noted to be 6/36 left eye and 6/9 right eye. Posterior segment examination revealed marked retinal ischaemia present in the posterior pole and macular region of both eyes. The appearance was not thought to be typical of diabetic changes, radiation retinopathy being the more likely diagnosis especially in view of his history. Over the next four months the vision in both eyes rapidly deteriorated to 3/6 left eye and 1/60 right eye. Bilateral pan retinal photocoagulation was thought to be appropriate treatment at this point. Conclusion: This case highlights the importance for ophthalmologists and oncologists to be aware of the close relationship between diabetes and radiation treatment and the profound rapid impact this combination of factors may have on visual function. Radiation is being used with increasing frequency for ocular and orbital disease, because of this more cases of radiation retinopathy may become prevalent. Factors which may potentiate radiation retinopathy should be well known including, increased radiation dosage, increased fraction size, concomitant systemic vascular disease and use of chemotherapy. Counselling should be offered in all cases at risk of visual loss. As no effective treatment currently exists to restore visual function, monitoring of visual acuity in all cases and early referral to the ophthalmologist as appropriate is warranted. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.